Clinical Trials Logo

Filter by:
NCT ID: NCT00253032 Terminated - Clinical trials for Chronic Musculoskeletal Pain

Pain Relief Investigation of NeuroModulation Therapy in Adult Humans

Start date: n/a
Phase: Phase 3
Study type: Interventional

The study is being performed to determine the efficacy and safety of Fralex Neuromodulation Therapy (F-NMT), delivered by the Fralex PRIMA device, in reducing chronic musculoskeletal pain.

NCT ID: NCT00257842 Terminated - Dyssynergia Clinical Trials

Randomized Controlled Trial of Biofeedback Therapy for Dyssynergic Defecation

Start date: n/a
Phase: N/A
Study type: Interventional

Constipation is a common disorder and current treatments are unsatisfactory. Biofeedback may help patients with constipation and dyssynergic defecation, but its efficacy is unproven and whether this is due to behavioral modification or excessive attention is unknown. Methods: In a prospective randomized trial, the investigators investigated the efficacy of Biofeedback (manometric- assisted anal relaxation, muscle coordination and simulated defecation training), with either sham feedback therapy (Sham) or standard therapy (diet, exercise, laxatives; Standard) in 77 subjects (69 women) with dyssynergic defecation. Primary outcome measures included presence of dyssynergia, balloon expulsion time, number of complete spontaneous bowel movements (CSBM), and global bowel satisfaction. Data analyzed per protocol.

NCT ID: NCT00265928 Terminated - Lymphoma Clinical Trials

Bortezomib and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

Start date: n/a
Phase: Phase 2
Study type: Interventional

RATIONALE: Bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread. Others find cancer cells and help kill them or carry cancer-killing substances to them. Giving bortezomib together with rituximab may be an effective treatment for non-Hodgkin's lymphoma. PURPOSE: This phase II trial is studying how well giving bortezomib together with rituximab works in treating patients with relapsed or refractory B-cell non-Hodgkin's lymphoma, including Waldenstrom's macroglobulinemia.

NCT ID: NCT00268047 Terminated - Clinical trials for Congenital Disorders

Pulmonary Resistance in Fontan Who Have Undergone Heart Transplantation

Start date: n/a
Phase: N/A
Study type: Observational

Clinical evidence reveals that some patients who undergo cardiac transplantation exhibit problems with pulmonary vascular resistance as well. In some studies, an increase in pulmonary vascular resistance has been used as an indicator for increased 3-day and 3-month mortality after heart transplantation2. In this study, the investigators would like to look at pulmonary vascular resistance in patients with a surgical history of the Fontan procedure followed by heart transplantation.

NCT ID: NCT00268086 Terminated - Clinical trials for Congenital Disorders

Constrictive Pericarditis in the Adult Congenital Cardiac Population

Start date: n/a
Phase: N/A
Study type: Observational

The primary aim of this study is to determine the clinical and radiographic findings with constrictive pericarditis in the adult congenital population and determine the degree of right heart failure and dilation from pulmonary insufficiency in the presence of constrictive pericarditis The secondary aim is to elucidate ways to better diagnose constrictive pericarditis and elucidate ways to diagnose right heart failure in the presence of constrictive pericarditis.

NCT ID: NCT00269100 Terminated - Bacteremia Clinical Trials

Prevention of Bacteremia Induced by Debridement of Pressure Ulcer

Start date: n/a
Phase: Phase 1/Phase 2
Study type: Observational

The purpose of this study is to analyse bacteremia induced by debridement of pressure ulcers in patients in the complex nursing department.

NCT ID: NCT00270426 Terminated - Clinical trials for Chronic Kidney Failure

Benazepril for Advanced Chronic Renal Insufficiency

Start date: n/a
Phase: N/A
Study type: Interventional

The purpose of this study is to further determine whether benazepril, could safely slow the progression of renal dysfunction in non-diabetic patients with advanced renal insufficiency.

NCT ID: NCT00272259 Terminated - Stroke Clinical Trials

Robots for Stroke Survivors

Start date: n/a
Phase: Phase 1
Study type: Interventional

The investigators are looking for individuals who have suffered a stroke to participate in an experiment examining the use of robotics in rehabilitation. They are trying to develop a robotic environment for hands after having had a stroke. Participants will interact with up to two small robots and a visual display. The experiment involves minimal risk and may involve testing sessions over multiple weeks. Subjects must be at least 1 year post-stroke and have difficulty picking up small objects. For more information, contact: Bambi Brewer, CMU Ph.D. Student, 412-241-9423 or bambi@andrew.cmu.edu.

NCT ID: NCT00277836 Terminated - Neoplasms Clinical Trials

Study Evaluating MST-997 in Advanced Malignant Solid Tumors

Start date: n/a
Phase: Phase 1
Study type: Interventional

MST-997 is a taxane analog with the potential to treat subjects with a variety of tumor types. Preclinical data demonstrated that MST-997 inhibited tumor growth when administered intravenously (IV). This phase 1 dose escalation study is designed to evaluate the safety and tolerability of if IV MST-997 formulated in Polysorbate 80 Diluent can be safely administered on a weekly basis.

NCT ID: NCT00277940 Terminated - Clinical trials for Congenital Disorders

Aortic Arch Reconstruction

Start date: n/a
Phase: N/A
Study type: Observational

Abnormalities of the aorta have been identified in patients who have undergone repair of coarctation of the aorta by various surgical techniques. These abnormalities are thought to contribute to ventricular hypertrophy, hypertension and exercise intolerance. Aortic arch reconstruction is performed for a variety of lesions besides simple coarctation of the aorta; these include hypoplastic left heart syndrome and its variants. In the latter group of patients extensive reconstruction is performed usually with a pulmonary homograft. We have previously shown that the neo-aortic dimensions and geometry are abnormal. The elastic properties of the neo-aorta, however, have not previously been described.